966
$100M$1B
108$10M$50M
201$10M$50M
164$10M$50M
501$50M$100M
146$10M$50MNektar Therapeutics uses 8 technology products and services including Microsoft Excel, Veeva Vault, Font Awesome, and more. Explore Nektar Therapeutics's tech stack below.
| Nektar Therapeutics Email Formats | Percentage |
| FLast@nektar.com | 74% |
| First.Last@nektar.com | 18% |
| LFirst@nektar.com | 7% |
| FiLast@nektar.com | 1% |
| FLast@therapeuticsinc.com | 86% |
| FirstLast@therapeuticsinc.com | 5% |
| Last@therapeuticsinc.com | 4% |
| FirstL@therapeuticsinc.com | 3% |
| FirstLas@therapeuticsinc.com | 1% |
| First@therapeuticsinc.com | 1% |
| FLast@odonate.com | 86% |
| Last_First@odonate.com | 2% |
| Last.F@odonate.com | 2% |
| First-Last@odonate.com | 3% |
| FirstLast@odonate.com | 2% |
| F.Last@odonate.com | 3% |
| FirstL@odonate.com | 1% |
| FiLast@odonate.com | 1% |
Biotechnology ResearchCalifornia, United States501-1000 Employees
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
Company Overview
Media & News
Funding & FinancialsNektar Therapeutics has raised a total of $30M of funding over 7 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $30M.
Nektar Therapeutics's revenue is in the range of $100M$1B
Funding & FinancialsNektar Therapeutics has raised a total of $30M of funding over 7 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $30M.
Nektar Therapeutics's revenue is in the range of $100M$1B
1-888-653-2347 
support@leadiq.com